Publikationen, an denen er mitarbeitet FERNANDO DOMINGUEZ PUENTE (10)

2022

  1. Silver Clusters of Five Atoms as Highly Selective Antitumoral Agents Through Irreversible Oxidation of Thiols

    Advanced Functional Materials, Vol. 32, Núm. 29

2013

  1. Anti-tumor efficacy of chitosan-g-poly(ethylene glycol) nanocapsules containing docetaxel: Anti-TMEFF-2 functionalized nanocapsules vs. non-functionalized nanocapsules

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 83, Núm. 3, pp. 330-337

2008

  1. Highly efficient system to deliver taxanes into tumor cells: Docetaxel-loaded chitosan oligomer colloidal carriers

    Biomacromolecules, Vol. 9, Núm. 8, pp. 2186-2193

  2. Hypochondroplasia and acanthosis nigricans: A new syndrome due to the p.Lys650Thr mutation in the fibroblast growth factor receptor 3 gene?

    European Journal of Endocrinology, Vol. 159, Núm. 3, pp. 243-249

1999

  1. Complex regulation of prothymosin alpha in mammary tumors arising in transgenic mice

    Life Sciences, Vol. 64, Núm. 23, pp. 2125-2133

1998

  1. Overexpression of prothymosin α accelerates proliferation and retards differentiation in HL-60 cells

    Biochemical Journal, Vol. 331, Núm. 3, pp. 753-761

  2. Prothymosin α stimulates Ca2+-dependent phosphorylation of elongation factor 2 in cellular extracts

    Journal of Biological Chemistry, Vol. 273, Núm. 17, pp. 10147-10152

  3. TGF-β1 actions on FRTL-5 cells provide a model for the physiological regulation of thyroid growth

    Oncogene, Vol. 16, Núm. 11, pp. 1455-1465

1997

  1. Development of ELISA to estimate thymosin α1, the N terminus of prothymosin α, in human tumors

    Clinical Chemistry, Vol. 43, Núm. 1, pp. 59-63

1995

  1. Regulation of thymosin β4 mRNA levels during cell proliferation

    Cell Proliferation, Vol. 28, Núm. 2, pp. 85-91